411 related articles for article (PubMed ID: 15752946)
21. Impact of abdominal obesity and ambulatory blood pressure in the diagnosis of left ventricular hypertrophy in never treated hypertensives.
Rodilla E; Costa JA; Martín J; González C; Pascual JM; Redon J
Med Clin (Barc); 2014 Mar; 142(6):235-42. PubMed ID: 24139053
[TBL] [Abstract][Full Text] [Related]
22. Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy.
Mureddu GF; Pasanisi F; Palmieri V; Celentano A; Contaldo F; de Simone G
J Hypertens; 2001 Jun; 19(6):1113-9. PubMed ID: 11403361
[TBL] [Abstract][Full Text] [Related]
23. Is there a relationship between left ventricular mass and plasma glucose and lipids independent of body mass index? Results of the Gubbio Study.
Ferrara AL; Vaccaro O; Cardoni O; Panarelli W; Laurenzi M; Zanchetti A
Nutr Metab Cardiovasc Dis; 2003 Jun; 13(3):126-32. PubMed ID: 12955793
[TBL] [Abstract][Full Text] [Related]
24. Subclassification of left ventricular hypertrophy based on dilation stratifies coronary artery disease patients with distinct risk.
Huang BT; Peng Y; Liu W; Zhang C; Huang FY; Wang PJ; Zuo ZL; Liao YB; Chai H; Li Q; Zhao ZG; Luo XL; Ren X; Huang KS; Meng QT; Chen C; Huang DJ; Chen M
Eur J Clin Invest; 2014 Oct; 44(10):893-901. PubMed ID: 25104141
[TBL] [Abstract][Full Text] [Related]
25. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
[TBL] [Abstract][Full Text] [Related]
26. Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance.
Chirinos JA; Segers P; De Buyzere ML; Kronmal RA; Raja MW; De Bacquer D; Claessens T; Gillebert TC; St John-Sutton M; Rietzschel ER
Hypertension; 2010 Jul; 56(1):91-8. PubMed ID: 20458004
[TBL] [Abstract][Full Text] [Related]
27. Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives.
Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Zanchetti A
J Hypertens; 2006 Aug; 24(8):1671-7. PubMed ID: 16877972
[TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study.
de Simone G; Devereux RB; Chinali M; Roman MJ; Lee ET; Resnick HE; Howard BV
Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):98-104. PubMed ID: 18674890
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis.
Zoccali C; Benedetto FA; Mallamaci F; Tripepi G; Giacone G; Cataliotti A; Seminara G; Stancanelli B; Malatino LS
J Am Soc Nephrol; 2001 Dec; 12(12):2768-2774. PubMed ID: 11729247
[TBL] [Abstract][Full Text] [Related]
30. Left ventricular hypertrophy evaluation in obese hypertensive patients: effect of left ventricular mass index criteria.
Rosa EC; Moyses VA; Sesso RC; Plavnik FL; Ribeiro FF; Kohlmann NE; Ribeiro AB; Zanella MT; Kohlmann O
Arq Bras Cardiol; 2002 Apr; 78(4):341-51. PubMed ID: 12011950
[TBL] [Abstract][Full Text] [Related]
31. Gender specific differences in left ventricular adaptation to obesity and hypertension.
Kuch B; Muscholl M; Luchner A; Döring A; Riegger GA; Schunkert H; Hense HW
J Hum Hypertens; 1998 Oct; 12(10):685-91. PubMed ID: 9819016
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women.
Salvetti G; Pucci A; Fierabracci P; Ceccarini G; Palagi C; Delle Donne MG; Di Bello V; Piaggi P; Vitti P; Salvetti A; Pinchera A; Santini F
High Blood Press Cardiovasc Prev; 2012 Mar; 19(1):33-9. PubMed ID: 22670585
[TBL] [Abstract][Full Text] [Related]
33. Prognostic implications of left ventricular hypertrophy defined by the thresholds from the international and Chinese guidelines.
Zhou D; Yan M; Cai A; Xie Q; Cheng Q; Tang S; Feng Y
J Clin Hypertens (Greenwich); 2023 Jul; 25(7):628-637. PubMed ID: 37334744
[TBL] [Abstract][Full Text] [Related]
34. Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy.
de Simone G; Izzo R; Losi MA; Stabile E; Rozza F; Canciello G; Mancusi C; Trimarco V; De Luca N; Trimarco B
J Hypertens; 2016 Sep; 34(9):1846-53. PubMed ID: 27367264
[TBL] [Abstract][Full Text] [Related]
35. Echocardiographic left ventricular mass in a multiethnic Southeast Asian population: proposed new gender and age-specific norms.
Wong RC; Yip JW; Gupta A; Yang H; Ling LH
Echocardiography; 2008 Sep; 25(8):805-11. PubMed ID: 18986407
[TBL] [Abstract][Full Text] [Related]
36. Self-reported weight and height: implications for left ventricular hypertrophy detection. An Italian multi-center study.
Cuspidi C; Negri F; Giudici V; Muiesan ML; Grandi AM; Ganau A; Lonati L; Degli Esposti D; Capra A; Milan A; Sala C; Longo M; Morganti A;
Clin Exp Hypertens; 2011; 33(3):192-201. PubMed ID: 21446894
[TBL] [Abstract][Full Text] [Related]
37. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities.
Chinali M; De Marco M; D'Addeo G; Benincasa M; Romano C; Galderisi M; de Simone G
J Hypertens; 2007 May; 25(5):1073-8. PubMed ID: 17414672
[TBL] [Abstract][Full Text] [Related]
38. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of left ventricular hypertrophy and carotid thickening in a large selected hypertensive population: impact of different echocardiographic and ultrasonographic diagnostic criteria.
Cuspidi C; Lonati L; Macca G; Sampieri L; Fusi V; Michev I; Severgnini B; Salerno M; Magrini F; Zanchetti A
Blood Press; 2001; 10(3):142-9. PubMed ID: 11688761
[TBL] [Abstract][Full Text] [Related]
40. Indexation of left ventricular mass to predict adverse clinical outcomes in pre-dialysis patients with chronic kidney disease: KoreaN cohort study of the outcome in patients with chronic kidney disease.
Lee SW; Min HK; Chae DW; Oh KH; Ahn C; Chung W; Lee J; Kim YS; Sung SA;
PLoS One; 2020; 15(5):e0233310. PubMed ID: 32428014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
